Human pluripotent stem cell tools for cardiac optogenetics

It is likely that arrhythmias should be avoided for therapies based on human pluripotent stem cell (hPSC)-derived cardiomyocytes (CM) to be effective. Towards achieving this goal, we introduced light-activated channelrhodopsin-2 (ChR2), a cation channel activated with 480 nm light, into human embryonic stem cells (hESC). By using in vitro approaches, hESC-CM are able to be activated with light. ChR2 is stably transduced into undifferentiated hESC via a lentiviral vector. Via directed differentiation, hESCChR2-CM are produced and subjected to optical stimulation. hESCChR2-CM respond to traditional electrical stimulation and produce similar contractility features as their wild-type counterparts but only hESCChR2-CM can be activated by optical stimulation. Here it is shown that a light sensitive protein can enable in vitro optical control of hESC-CM and that this activation occurs optimally above specific light stimulation intensity and pulse width thresholds. For future therapy, in vivo optical stimulation along with optical inhibition could allow for acute synchronization of implanted hPSC-CM with patient cardiac rhythms.

[1]  Oscar J. Abilez,et al.  Optogenetic LED array for perturbing cardiac electrophysiology , 2013, 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[2]  Sean P. Palecek,et al.  Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells , 2009, Circulation research.

[3]  Atsushi Izawa,et al.  hESC-Derived Cardiomyocytes Electrically Couple and Suppress Arrhythmias in Injured Hearts , 2012, Nature.

[4]  B. Thiers.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2008 .

[5]  José Jalife,et al.  Optical Imaging of Voltage and Calcium in Cardiac Cells & Tissues , 2012, Circulation research.

[6]  Aristides B. Arrenberg,et al.  Optogenetic Control of Cardiac Function , 2010, Science.

[7]  K. Deisseroth,et al.  Circuit-breakers: optical technologies for probing neural signals and systems , 2007, Nature Reviews Neuroscience.

[8]  K. Deisseroth,et al.  Orderly recruitment of motor units under optical control in vivo , 2010, Nature Medicine.

[9]  R. Stewart,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[10]  Karl Deisseroth,et al.  Functional Control of Transplantable Human ESC‐Derived Neurons Via Optogenetic Targeting , 2010, Stem cells.

[11]  Karl Deisseroth,et al.  Multiscale computational models for optogenetic control of cardiac function. , 2011, Biophysical journal.

[12]  Euan A Ashley,et al.  Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. , 2013, Cell stem cell.

[13]  K. Deisseroth,et al.  Molecular and Cellular Approaches for Diversifying and Extending Optogenetics , 2010, Cell.

[14]  Ron Weiss,et al.  Formation and optogenetic control of engineered 3D skeletal muscle bioactuators. , 2012, Lab on a chip.

[15]  Nigel J. Cassidy,et al.  Electrical stimulation: a novel tool for tissue engineering. , 2013, Tissue engineering. Part B, Reviews.

[16]  Jonathan Wong,et al.  Computational Optogenetics: A Novel Continuum Framework for the Photoelectrochemistry of Living Systems. , 2012, Journal of the mechanics and physics of solids.

[17]  Linda Greensmith,et al.  Optical Control of Muscle Function by Transplantation of Stem Cell–Derived Motor Neurons in Mice , 2014, Science.

[18]  K. Chien,et al.  Regenerative medicine and human models of human disease , 2008, Nature.

[19]  T. Bruegmann,et al.  Optogenetic control of heart muscle in vitro and in vivo , 2010, Nature Methods.

[20]  Euan A. Ashley,et al.  Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated Cardiomyopathy , 2012, Science Translational Medicine.

[21]  E. Entcheva.  Cardiac optogenetics. , 2013, American journal of physiology. Heart and circulatory physiology.

[22]  Guy Salama,et al.  Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia , 2007, Nature.

[23]  K. Deisseroth,et al.  Millisecond-timescale, genetically targeted optical control of neural activity , 2005, Nature Neuroscience.